Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
PBYI | PUMA BIOTECHNOLOGY, INC. | Dorval Allison | Director | Jun 13, 2024 | Sale | $3.37 | 11,000 | 37,096 | 33,000 | Jun 17, 2024, 07:18 PM | |
VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Nov 29, 2023 | Sale | $11.45 | 554 | 6,343 | 4,060 | Dec 01, 2023, 04:30 PM | |
PBYI | PUMA BIOTECHNOLOGY, INC. | Dorval Allison | Director | Jun 13, 2023 | Sale | $3.45 | 10,000 | 34,500 | 17,000 | Jun 15, 2023, 09:01 PM | |
VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Nov 29, 2022 | Sale | $22.10 | 554 | 12,243 | 2,186 | Dec 01, 2022, 05:00 PM | |
VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Feb 11, 2021 | Sale | $7.55 | 3,186 | 24,054 | 45,894 | Feb 16, 2021, 04:10 PM | |
VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Jan 12, 2021 | Sale | $8.62 | 2,942 | 25,360 | 49,080 | Jan 14, 2021, 05:57 PM | |
VYGR | Voyager Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | Jan 21, 2020 | Sale | $13.36 | 3,128 | 41,790 | 24,522 | Jan 29, 2020, 05:27 PM | |
PODD | INSULET CORP | Dorval Allison | Chief Financial Officer | Apr 01, 2015 | Option Exercise | $31.85 | 814 | 25,926 | 37,415 | Apr 03, 2015, 04:24 PM | |
PODD | INSULET CORP | Dorval Allison | Chief Financial Officer | Mar 03, 2015 | Option Exercise | $31.37 | 851 | 26,696 | 38,229 | Mar 04, 2015, 07:06 PM | |
PODD | INSULET CORP | Dorval Allison | Chief Financial Officer | Mar 01, 2015 | Option Exercise | $31.73 | 1,091 | 34,617 | 28,827 | Mar 03, 2015, 05:59 PM |